[go: up one dir, main page]

ES2146665T3 - Nuevos compuestos 14-aminoesteroides que contienen oligosacaridos y nuevo procedimiento en quimica de aminoesteroides diastereoselectivo. - Google Patents

Nuevos compuestos 14-aminoesteroides que contienen oligosacaridos y nuevo procedimiento en quimica de aminoesteroides diastereoselectivo.

Info

Publication number
ES2146665T3
ES2146665T3 ES94929315T ES94929315T ES2146665T3 ES 2146665 T3 ES2146665 T3 ES 2146665T3 ES 94929315 T ES94929315 T ES 94929315T ES 94929315 T ES94929315 T ES 94929315T ES 2146665 T3 ES2146665 T3 ES 2146665T3
Authority
ES
Spain
Prior art keywords
hydrogen
lower alkyl
acetoxy
carbon lower
benzoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94929315T
Other languages
English (en)
Inventor
Paul Michael Dybas
Roland Norman Johnson
Randy Stuart Muth
Song Liu
David Edward Portlock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of ES2146665T3 publication Critical patent/ES2146665T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011Unsubstituted amino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005Glycosides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J19/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
    • C07J19/005Glycosides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • External Artificial Organs (AREA)
  • Centrifugal Separators (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPOSICIONES 14AMINOESTEROIDES QUE CONTIENEN OLIGOSACARIDOS Y A ESTERES O SALES ACIDAS DE LAS MISMAS DE LA FORMULA GENERAL (I), EN LA QUE A) R1 ES (I) COOR5, DONDE R5 ES HIDROGENO, UN ALQUILO BAJO 1-6 CARBONO; UN ALQUILO BAJO 1-6 CARBONO SUSTITUIDO POR UN GRUPO AMINO; UN ARILALQUILO O HETEROARILALQUILO O UN ANILLO CARBOCICLICO, O (II) CHR6-OH, DONDE R6 ES UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO BAJO 1-6 CARBONO, O (III) COR'''''' DONDE R'''''' ES HIDROGENO; ALQUILO BAJO CARBONO 1-6; UN ALQUILO BAJO CARBONO 1-6 AMINO SUSTITUIDO; AMINO O DIALQUILAMINO; Y R2 ES NR7R8, DONDE R7 Y R8, QUE PUEDEN SE IGUALES O DIFERENTES, SON ATOMOS DE HIDROGENO O UN ALQUILO BAJO CARBONO 1-6; Y C) R3 ES (I) UN RESIDUO DE AZUCAR OLIGOSACARIDO QUE TIENE UNA ESTRUCTURA (II), DONDE R10 ES HIDROGENO; METILO; HIDROXI; CARBOXI; ACETOXI, ARILALQUILOXI, HETEROARILALQUILOXI, BENZOXI O HIDROXI; R11 ES OXIGENO; DONDE ADEMAS R11 ES UN SUSTITUYENTE EN EL RESIDUO DE AZUCAR MONOSACARIDO TERMINAL; R11 ES OH; METILO; ACETOXI; ARILALQUILOXI, HETEROARILALQUILOXI, Y R12 ES UN HIDROGENO; METILO; METILHIDROXIMETILO; O ACETOXIMETILO; O (II) UN RESIDUO DE AZUCAR OLIGOSACARIDO QUE TIENE UNA ESTRUCTURA (III), DONDE R14 Y R15}, QUE PUEDEN SER IGUALES O DIFERENTES SON HIDROGENO, ALQUILO BAJO 1-6 CARBONO; HETEROARILALQUILO; ARILALQUILO, HETEROARILO O ARILO; R17 PUEDE SER HIDROGENO; HIDROXI, ACETOXI, BENZOXI, R18 Y R19 SON HIDROXI, ACETOXI Y BENZOXI; O (III) UN RESIDUO OLIGOSACARIDO QUE TIENE UNA ESTRUCTURA (IV), DONDE R14 Y R15}, QUE PUEDEN SER IGUALES O DIFERENTES, SON HIDROGENO; ALQUILO BAJO 1-6 CARBONO; ARIALQUILO, HETERORARILO O ARILO; R14A ES OXIGENO; DONDE ADEMAS R14A ES UN SUSTITUYENTE EN EL RESIDUO DE AZUCAR MONOSACARIDO TERMINAL; R14A DEBE SER HIDROXI; METILO, ACETOXI; ARIALQUILOXI O HETEROARILALQUILOXI; Y D) R4 ES Y E) Z ES (I) OH, O (II) H O (III) OR13}, DONDE R13 ES UN RESTADO DE AZUCAR MONOSACARIDO; ACETOXI; BENZOXI; ARIALQUIL O HETEROARILALQUIL; Y E) Z ES (I)-CH-, DONDE A Y B SON ENLACES SIMPLES, O (II) OR13}, DONDE R13 ES UN RESIDUO DE AZUCAR MONOSACARIDO; ACETOXI, BENZOXI, ARIALQUILO O HETEROARILALQUILO; Y E) Z ES (I)-CH-, DONDE A Y B SON ENLACES SIMPLES, O (II)=C, DONDE TANTO A COMO B ES UN ENLACE DOBLE. LA PRESENTE INVENCION TAMBIEN SE REFIERE AL PROCESO PARA INTRODUCIR UN GRUPO AMINO EN LA POSICION 14 DE UN NUCLEO ESTEROIDE DONDE DICHO GRUPO AMINO ES INTRODUCIDO DIASTEREOSELECTIVAMENTE EN LA POSICION 14 DEL NUCLEO ESTEROIDE A TRAVES DE UNA ADICION DE YODOISOCIANATO QUE COMPRENDE LAS FASES DE: A) AÑADIR EL YODOISOCIANATO A LA ENLACE DOBLE DE LA POSICION 14-15 DEL NUCLEO ESTEROIDE Y B) DESHALOGENACION; Y C) CONVERSION DEL ISOCIANATO A LA MITAD AMINA DE LA POSICION 14 DEL NUCLEO ESTEROIDE.
ES94929315T 1993-09-24 1994-09-23 Nuevos compuestos 14-aminoesteroides que contienen oligosacaridos y nuevo procedimiento en quimica de aminoesteroides diastereoselectivo. Expired - Lifetime ES2146665T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12645993A 1993-09-24 1993-09-24

Publications (1)

Publication Number Publication Date
ES2146665T3 true ES2146665T3 (es) 2000-08-16

Family

ID=22424936

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94929315T Expired - Lifetime ES2146665T3 (es) 1993-09-24 1994-09-23 Nuevos compuestos 14-aminoesteroides que contienen oligosacaridos y nuevo procedimiento en quimica de aminoesteroides diastereoselectivo.

Country Status (19)

Country Link
US (2) US5710259A (es)
EP (2) EP0863149A1 (es)
JP (1) JPH09502982A (es)
KR (1) KR960704914A (es)
CN (1) CN1135758A (es)
AT (1) ATE193538T1 (es)
AU (1) AU692187B2 (es)
BR (1) BR9407612A (es)
CA (1) CA2182530A1 (es)
CZ (1) CZ86696A3 (es)
DE (1) DE69424794D1 (es)
DK (1) DK0721459T3 (es)
ES (1) ES2146665T3 (es)
GR (1) GR3034028T3 (es)
HU (1) HUT74623A (es)
NO (1) NO961170L (es)
PL (1) PL313620A1 (es)
RU (1) RU2153503C2 (es)
WO (1) WO1995008557A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922703A (en) * 1993-09-24 1999-07-13 The Procter & Gamble Company Urethane-containing aminosteroid compounds
CA2563008C (en) * 2004-04-15 2010-01-05 Chr. Hansen A/S Method for reducing the content of pathogenic organisms present in food materials
CA2954662C (en) 2014-07-09 2024-03-19 Midori Usa, Inc. Oligosaccharide compositions and methods for producing thereof
EP4209130A1 (en) 2015-01-26 2023-07-12 DSM Nutritional Products, LLC Oligosaccharide compositions for use animal feed and methods of producing thereof
RU2017130166A (ru) * 2015-01-26 2019-02-28 Кадена Байо, Инк. Олигосахаридные композиции для применения в качестве пищевых ингредиентов и способы их получения
SI3285777T1 (sl) 2015-04-23 2022-02-28 Kaleido Biosciences, Inc. Glikanski terapevtiki in postopki zdravljenja

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567712A (en) * 1966-10-31 1971-03-02 Lepetit Spa 10beta-amino-estranes and method for the preparation thereof
FR2464270A1 (fr) * 1979-08-31 1981-03-06 Nativelle Sa Ets Nouveaux derives d'amino-14 steroides, et procede pour leur preparation
ES8404693A1 (es) * 1982-08-12 1984-05-01 Nativelle Sa Ets Procedimiento de preparacion de nuevos amino-14 esteroides.
NZ205293A (en) * 1982-08-20 1986-12-05 Nativelle Sa Ets 14-aminosteroids and pharmaceutical compositions
ES524796A0 (es) * 1982-08-20 1984-05-01 Nativelle Sa Ets Procedimiento de preparacion de nuevos derivos de amino-14 esteroides
DD256134A1 (de) * 1985-06-06 1988-04-27 Akad Wissenschaften Ddr Verfahren zur herstellung von derivaten von cardenoliden und cardenolidanalogen verbindungen
US5175281A (en) * 1985-09-12 1992-12-29 The Upjohn Company Pharmaceutically active pyrimidinylpiperazinylsterioids
GB8600490D0 (en) * 1986-01-09 1986-02-12 Erba Farmitalia Aminoglycoside norcholanic acid lactams
FR2621316B1 (fr) * 1987-10-02 1991-06-21 Nativelle Sa Ets Nouveaux esters d'acide androstane 17-carboxylique, procede pour leur preparation, et medicament les contenant
US5144017A (en) * 1988-07-13 1992-09-01 University Of Manitoba Compounds that bind to digitalis receptor
FR2642973A1 (fr) * 1989-02-03 1990-08-17 Cote Ivoire Ministere Rech Sc Composition medicamenteuse renfermant comme principe actif un derive glucidique dioxymethyle de la strophanthidine
WO1991017176A2 (en) * 1990-05-07 1991-11-14 The Board Of Regents Of The University Of Washington Novel steroid glycosides useful in the early detection of hypertension
JPH0429089A (ja) * 1990-05-25 1992-01-31 Toshiba Corp 燃料集合体
WO1993005790A1 (en) * 1991-09-27 1993-04-01 Procter & Gamble Pharmaceuticals, Inc. Use of 14-aminosteroids for the manufacture of a medicament to slow the rate of progression of myocardial structural damages characteristic of congestive heart failure
CN1135757A (zh) * 1993-09-24 1996-11-13 普罗克特和甘保尔公司 新型含脱氧和氧被取代的糖的14-氨基类固醇
US5922703A (en) * 1993-09-24 1999-07-13 The Procter & Gamble Company Urethane-containing aminosteroid compounds

Also Published As

Publication number Publication date
PL313620A1 (en) 1996-07-08
RU2153503C2 (ru) 2000-07-27
ATE193538T1 (de) 2000-06-15
HU9600734D0 (en) 1996-05-28
HUT74623A (en) 1997-01-28
AU692187B2 (en) 1998-06-04
US5849889A (en) 1998-12-15
CA2182530A1 (en) 1995-03-30
AU7841494A (en) 1995-04-10
BR9407612A (pt) 1997-01-14
GR3034028T3 (en) 2000-11-30
EP0721459B1 (en) 2000-05-31
NO961170L (no) 1996-05-24
DK0721459T3 (da) 2000-08-07
CZ86696A3 (en) 1996-10-16
KR960704914A (ko) 1996-10-09
DE69424794D1 (de) 2000-07-06
US5710259A (en) 1998-01-20
CN1135758A (zh) 1996-11-13
EP0863149A1 (en) 1998-09-09
WO1995008557A1 (en) 1995-03-30
JPH09502982A (ja) 1997-03-25
NO961170D0 (no) 1996-03-22
EP0721459A1 (en) 1996-07-17

Similar Documents

Publication Publication Date Title
IL99889A0 (en) Azasteroid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IE870586L (en) Cyclodextrin clathrates of carbacyclin derivatives.
KR920018049A (ko) 이미다조피리딘
HUT59935A (en) Process for producing o-methyl-derivatives of azitormycin a and pharmaceutical compositions containing them as active components
ATE39489T1 (de) Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel.
CA2290709A1 (en) 2,6-diaminopyridine compounds as intermediates for producing antibacterial dihydropyridone carboxylic acid derivatives
EP0870765A4 (es)
HU9602466D0 (en) Naphthalene derivatives as prostaglandin i2 agonits
AU2576795A (en) Novel compound, process for producing the same, and antitumor agent
MY132263A (en) Pyridazinone derivatives and processes for preparing the same
IE41528L (en) Furfuryl-benzomorphane derivatives.
ES2146665T3 (es) Nuevos compuestos 14-aminoesteroides que contienen oligosacaridos y nuevo procedimiento en quimica de aminoesteroides diastereoselectivo.
GB1519636A (en) Derivatives of histidyl-prolinamide
ATE44748T1 (de) 4-substituierte 6-alkylidene-androsten-3,17-dion- derivate und verfahren zu ihrer herstellung.
AU3381389A (en) Derivative of caffeic acid and pharmaceutical composition containing the same
MX9800904A (es) Proceso para producir derivados de eritromicina.
ES2103161A1 (es) Derivados de cicloheptimidazol, metodo de fabricacion de los mismos y agentes terapeuticos que contienen estos compuestos.
IL132799A0 (en) 17Beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
TW336235B (en) 3'-aziridino-anthracycline derivatives, process for preparating them and pharmaceutical composition containing them
ATE18228T1 (de) Neue thieno-thiazol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
AU3285000A (en) 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
AU1589695A (en) Bicyclic amino group-substituted pyridonecarboxylic acid derivatives, esters thereof and salts thereof, and bicyclic amines useful as intermediates thereof
ES385518A1 (es) Procedimiento para la obtencion de compuestos de 4-amino- spiro (ciclohexan-1,9'-tioxanteno).
ES8707518A1 (es) Un procedimiento para preparar nuevos derivados del 1,3-ben-zoxatiol
DK259387D0 (da) Steroide forbindelser, der er virksomme mod kraeft og obesitet

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 721459

Country of ref document: ES